Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?

1. Regele H, Mougenot B, Brown P et al. Report from Pathology Consensus Meeting on Renal Biopsy Handling and Processing, Vienna, February 25, 2000 (http://www.kidney-euract.org/ Rbpathologyconsensus.htm) 2. Thut MP, Uehlinger D, Steiger J, Mihatsch MJ. Renal biopsy: standard procedure of modern nephrology. Ther Umsch 2002; 59: 110–116 3. Paone DB, Meyer LE. The effect of biopsy on therapy in renal disease. Arch Intern Med 1981; 141: 1039–1041 4. Fuiano G, Mazza G, Comi N et al. Current indications for renal biopsy: a questionnaire-based survey. Am J Kidney Dis 2000; 35: 448–457 5. Andreucci VE, Fuiano G, Stanziale P, Andreucci M. Role of renal biopsy in the diagnosis and prognosis of acute renal failure. Kidney Int Suppl 1998; 66: S91–S95 6. Cameron JS. Indications for renal biospy, history of the procedure, and relationship of the findings to further investigation and treatment. In: Solez K, Racusen L, Olsen S, eds. Diagnostic Renal Pathology. Transpath Inc. (http://www. transpath.com/m-media/DRP.htm) 7. Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988; 8: 85–89 8. McCarthy GP, Roberts IS. Diagnosis of acute renal allograft rejection: evaluation of the Banff 97 Guidelines for Slide Preparation. Transplantation 2002; 73: 1518–1521 9. Amann K. New parameters in kidney biopsy diagnosticmorphometry. Kidney Blood Press Res 2000; 23: 181–182 10. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242–251 11. Böhmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibodydependent graft injury. J Am Soc Nephrol 2002; 13: 1091–1099